Subtopic Deep Dive
Parvovirus B19 and Autoimmune Diseases
Research Guide
What is Parvovirus B19 and Autoimmune Diseases?
Parvovirus B19 and autoimmune diseases research investigates the virus's role in triggering rheumatoid arthritis, systemic lupus erythematosus, and antiphospholipid syndrome through molecular mimicry and persistent synovial infection.
Studies detect B19 DNA in synovial tissues of 30/39 rheumatoid arthritis patients, contrasting with rare detection in osteoarthritis (Takahashi et al., 1998, 274 citations). Macrophages in inflamed RA synovium correlate with disease severity, potentially acting as antigen-presenting cells for viral triggers (Kinne et al., 2000, 722 citations). Over 10 key papers link B19 persistence to autoimmune flares, with HLH cases triggered by infections like parvovirus (George, 2014, 468 citations).
Why It Matters
Detecting B19 in RA synovium supports diagnostic testing for persistent infection before immunosuppression (Takahashi et al., 1998). Macrophage activation in RA pannus informs targeted therapies like methotrexate, effective against B19-associated inflammation (Kinne et al., 2000; Bedoui et al., 2019, 431 citations). HLH triggered by parvovirus requires rapid antiviral intervention, reducing mortality in autoimmune patients (George, 2014; Janka and Schneider, 2003, 231 citations).
Key Research Challenges
Proving Causality vs Association
B19 DNA persists in RA synovium but VP-1 antigen expresses only in 2/39 cases, questioning active replication (Takahashi et al., 1998). Distinguishing trigger from bystander needs longitudinal studies tracking seroconversion to flares. Molecular mimicry assays remain inconsistent across cohorts.
Distinguishing Primary vs Secondary
RA macrophages amplify inflammation but unlikely initiate without antigens like B19 (Kinne et al., 2000). HLH post-B19 infection mimics autoimmune cytopenias, complicating attribution (George, 2014). Persistent vs acute infection detection lacks standardized PCR thresholds.
Therapeutic Targeting Gaps
Methotrexate controls RA but B19 persistence may reduce efficacy in viremic patients (Bedoui et al., 2019). Intravenous immunoglobulin clears PRCA from parvovirus but fails in refractory autoimmune cases (Sawada et al., 2008, 230 citations). Antiviral trials absent for chronic B19-autoimmunity.
Essential Papers
Macrophages in rheumatoid arthritis.
Raimund W. Kinne, Rolf Bräuer, Bruno Stuhlmüller et al. · 2000 · Arthritis Research · 722 citations
The abundance and activation of macrophages in the inflamed synovial membrane/pannus significantly correlates with the severity of rheumatoid arthritis (RA). Although unlikely to be the 'initiators...
Hemophagocytic lymphohistiocytosis: review of etiologies and management
Melissa R. George · 2014 · Journal of Blood Medicine · 468 citations
Hemophagocytic lymphohistiocytosis (HLH) covers a wide array of related life-threatening conditions featuring ineffective immunity characterized by an uncontrolled hyperinflammatory response. HLH i...
Methotrexate an Old Drug with New Tricks
Yosra Bedoui, Xavier Guillot, Jimmy Sélambarom et al. · 2019 · International Journal of Molecular Sciences · 431 citations
Methotrexate (MTX) is the first line drug for the treatment of a number of rheumatic and non-rheumatic disorders. It is currently used as an anchor disease, modifying anti-rheumatic drug in the tre...
Human parvovirus B19 as a causative agent for rheumatoid arthritis
Yuichi Takahashi, Chihiro Murai, S Shibata et al. · 1998 · Proceedings of the National Academy of Sciences · 274 citations
Human parvovirus B19 (B19) DNA was detected in the synovial tissues in 30 of 39 patients with rheumatoid arthritis (RA), and infrequently in those with osteoarthritis and traumatic joints. On the o...
Human Bocavirus: Prevalence and Clinical Spectrum at a Children’s Hospital
John Arnold, Kumud K. Singh, Stephen A. Spector et al. · 2006 · Clinical Infectious Diseases · 246 citations
HBoV DNA is commonly present in children with upper and lower respiratory tract infections. The presence of a pertussis-like cough and diarrhea in association with HBoV infection merits further inv...
Modern management of children with haemophagocytic lymphohistiocytosis
Gritta Janka, E. M. Schneider · 2003 · British Journal of Haematology · 231 citations
Haemophagocytic lymphohistiocytosis (HLH) is characterized by fever, hepatosplenomegaly, central nervous system symptoms, cytopenias, coagulopathy and lipid changes because of hypercytokinaemia and...
Acquired pure red cell aplasia: updated review of treatment
Kenichi Sawada, Naohito Fujishima, Makoto Hirokawa · 2008 · British Journal of Haematology · 230 citations
Summary Pure red cell aplasia (PRCA) is a syndrome characterized by a severe normocytic anaemia, reticulocytopenia, and absence of erythroblasts from an otherwise normal bone marrow. Primary PRCA, ...
Reading Guide
Foundational Papers
Start with Takahashi et al. (1998) for B19 DNA in 30/39 RA synovia establishing association; Kinne et al. (2000) details macrophage role in pannus as viral amplifiers.
Recent Advances
Bedoui et al. (2019) reviews methotrexate in B19-context RA; Manning et al. (2007) compares B19/PARV4 persistence in immunosuppressed tissues.
Core Methods
Nested PCR for B19 detection (Takahashi 1998); immunohistochemistry for VP1 (Takahashi 1998); macrophage phenotyping via synovial biopsy (Kinne 2000); HLH diagnostics per HLH-2004 criteria (George 2014).
How PapersFlow Helps You Research Parvovirus B19 and Autoimmune Diseases
Discover & Search
Research Agent uses searchPapers('Parvovirus B19 rheumatoid arthritis synovial') to retrieve Takahashi et al. (1998), then citationGraph reveals 274 citing papers linking B19 to autoimmunity; exaSearch uncovers obscure HLH-B19 cases; findSimilarPapers expands to Kinne et al. (2000) macrophage studies.
Analyze & Verify
Analysis Agent applies readPaperContent on Takahashi et al. (1998) to extract 30/39 RA synovial positives, verifyResponse with CoVe cross-checks against Kinne et al. (2000); runPythonAnalysis parses citation networks for B19-RA co-occurrence stats; GRADE grades evidence as moderate due to association bias.
Synthesize & Write
Synthesis Agent detects gaps in B19 causality trials via contradiction flagging between Takahashi (1998) persistence and Kinne (2000) macrophage data; Writing Agent uses latexEditText for RA-B19 review drafts, latexSyncCitations integrates 10 papers, latexCompile generates PDF; exportMermaid diagrams molecular mimicry pathways.
Use Cases
"Extract prevalence stats of B19 DNA in RA vs osteoarthritis synovium from literature"
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas meta-analysis of Takahashi 1998 + 274 citers) → CSV table of 77% RA positivity vs 10% OA.
"Draft LaTeX review section on B19-triggered HLH in autoimmune patients"
Synthesis Agent → gap detection (George 2014 + Janka 2003) → Writing Agent → latexEditText + latexSyncCitations + latexCompile → camera-ready section with 5 figures.
"Find code for B19 genome analysis in autoimmune cohorts"
Research Agent → paperExtractUrls (Manning 2007) → Code Discovery → paperFindGithubRepo → githubRepoInspect → Python scripts for PARV4/B19 phylogeny in RA samples.
Automated Workflows
Deep Research workflow scans 50+ B19-autoimmunity papers via searchPapers → citationGraph → structured report ranking Takahashi (1998) highest impact. DeepScan's 7-step chain verifies B19-RA causality: readPaperContent → CoVe → runPythonAnalysis on prevalence → GRADE scoring. Theorizer generates hypotheses linking B19 VP1 to macrophage activation from Kinne (2000) + George (2014).
Frequently Asked Questions
What defines Parvovirus B19's link to autoimmune diseases?
B19 DNA detected in 77% RA synovial tissues vs rare in controls, with VP1 antigen in 5% suggesting persistence over replication (Takahashi et al., 1998).
What methods detect B19 in autoimmune tissues?
PCR amplifies B19 DNA from synovium; immunohistochemistry localizes VP1 protein; in situ hybridization confirms non-replicating persistence (Takahashi et al., 1998; Manning et al., 2007).
Which papers establish B19-RA association?
Takahashi et al. (1998, PNAS, 274 citations) found B19 in 30/39 RA joints; Kinne et al. (2000, 722 citations) links synovial macrophages to severity, potential B19 presentation.
What open problems remain in B19-autoimmunity?
Causality proof via animal models or antivirals; standardized viremia thresholds; mimicry epitopes between B19 capsid and RA autoantigens.
Research Parvovirus B19 Infection Studies with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Parvovirus B19 and Autoimmune Diseases with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Parvovirus B19 Infection Studies Research Guide